Ausgabe 4/2024
Inhalt (10 Artikel)
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Teijo I. Saari, John Strang, Ola Dale
Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors
Mei Tang, Amit Garg, Peter L. Bonate, Jonathan E. Rosenberg, Maria Matsangou, Takeshi Kadokura, Akihiro Yamada, Mary Choules, Janet Pavese, Masanori Nagata, Daisuke Tenmizu, Akira Koibuchi, Nakyo Heo, Lu Wang, Tomasz Wojtkowski, William D. Hanley, Srinivasu Poondru
Have We Neglected to Study Target-Site Drug Exposure in Children? A Systematic Review of the Literature
Eline Hermans, Jozefien Meersschaut, Isis Van herteryck, Mathias Devreese, Johan Vande Walle, Peter De Paepe, Pieter A. De Cock
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers
Brit S. Rohr, Evelyn Krohmer, Kathrin I. Foerster, Jürgen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter E. Haefeli
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration
Joseph Piscitelli, Micaela B. Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Linda Wood, Yizhong Zhang, Kyle Matschke, Jason H. Williams
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study
Sammy Huygens, Tim Preijers, Francis H. Swaneveld, Ilona Kleine Budde, Corine H. GeurtsvanKessel, Birgit C. P. Koch, Bart J. A. Rijnders
Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation
Alex Yu, Anasuya Hazra, James Juhui Jiao, Peter Hellemans, Anna Mitselos, Hui Tian, Juan Jose Perez Ruixo, Nahor Haddish-Berhane, Daniele Ouellet, Alberto Russu
Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease
Nanja C. Bevers, Ron J. Keizer, Dennis R. Wong, Arta Aliu, Marieke J. Pierik, Luc J. J. Derijks, Patrick F. van Rheenen
Optimization of Ganciclovir and Valganciclovir Starting Dose in Children by Machine Learning
Laure Ponthier, Julie Autmizguine, Benedicte Franck, Anders Åsberg, Philippe Ovetchkine, Alexandre Destere, Pierre Marquet, Marc Labriffe, Jean-Baptiste Woillard
Population Pharmacodynamic Dose–Response Analysis of Serum Potassium Following Dosing with Sodium Zirconium Cyclosilicate
Robert C. Penland, Magnus Åstrand, David W. Boulton, Mats Någård